Onbrez Breezhaler 150 mcg

Onbrez Breezhaler 150 mcg is a medicine authorised by Swissmedic under authorisation number 60141. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 May 2010 and the authorisation is valid without a time limit. ATC code R03AC18 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 60141
  • ATC R03AC18
  • Synthetic medicines
Authorisation data
Authorisation number60141
NameOnbrez Breezhaler 150 mcg
Full nameOnbrez Breezhaler 150 mcg, Pulver Hartkapseln zur Inhalation (mit Inhalator)
Authorisation holderNovartis Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeR03AC18
First authorisation21 May 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Onbrez Breezhaler 150 mcg, Pulver Hartkapseln zur Inhalation (mit Inhalator)B21 May 2010
2Onbrez Breezhaler 300 mcg, Pulver Hartkapseln zur Inhalation (mit Inhalator)B21 May 2010

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Kapsel(n)R03AC1803.04.3.B
390Kapsel(n)R03AC1803.04.3.B
590Kapsel(n)R03AC1803.04.3.B
230Kapsel(n)R03AC1803.04.3.B
490Kapsel(n)R03AC1803.04.3.B
690Kapsel(n)R03AC1803.04.3.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Onbrez Breezhaler 150 mcg authorised in Switzerland?

Yes. Onbrez Breezhaler 150 mcg is authorised by Swissmedic under authorisation number 60141, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Onbrez Breezhaler 150 mcg have?

Onbrez Breezhaler 150 mcg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Onbrez Breezhaler 150 mcg?

The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com